Original Paper

Archives of Dermatological Research

, Volume 305, Issue 2, pp 113-116

First online:

Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis

  • Hidetoshi TakahashiAffiliated withDepartment of Dermatology, Asahikawa Medical University Email author 
  • , Hitomi TsujiAffiliated withDepartment of Dermatology, Asahikawa Medical University
  • , Masaru HonmaAffiliated withDepartment of Dermatology, Asahikawa Medical University
  • , Akemi Ishida-YamamotoAffiliated withDepartment of Dermatology, Asahikawa Medical University
  • , Hajime IizukaAffiliated withDepartment of Dermatology, Asahikawa Medical University

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Psoriasis is associated with obesity accompanied by insulin resistance. A recent study disclosed increased plasma resistin and decreased plasma omentin levels in obesity. Few studies of plasma levels of resistin and omentin are available in psoriasis. We analyzed plasma levels of resistin and omentin in psoriasis and compared them with those of healthy controls. Evaluation of plasma levels of resistin and omentin was performed by enzyme-linked immunosorbent assay (ELISA) for 62 psoriasis patients and 58 healthy controls. The severity of psoriasis was evaluated by psoriasis area and severity index (PASI) score. Plasma levels of resistin were significantly increased in psoriasis as compared with those of healthy controls. In contrast, plasma levels of omentin were significantly decreased in psoriasis patients. Plasma levels of resistin and omentin were positively and negatively correlated with PASI scores, respectively. After the treatment of psoriasis, resistin levels were decreased and omentin levels were increased, respectively, compared with those of pretreated. Plasma levels of resistin and omentin might be useful for evaluating the disease activity of psoriasis.

Keywords

Disease activity Omentin Resistin Psoriasis